A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (ARNASA) - Trial PHRR230822-006034
Access comprehensive clinical trial information for PHRR230822-006034 through Pure Global AI's free database. This Phase 3 trial is sponsored by F. Hoffmann-La Roche Ltd. and is currently Ongoing. The study focuses on Chronic Obstructive Pulmonary Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Philippine Health Research Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
PHRR230822-006034
Phase 3
Ongoing
Trial Details
Philippine Health Research Registry • PHRR230822-006034
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (ARNASA)
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease
Study Focus
Interventional
Sponsor & Location
F. Hoffmann-La Roche Ltd.
Argentina;Australia;Austria;Belgium;Brazil;Bulgaria;Canada;Chile;China;Czech;Republic;Denmark;Egypt;
Timeline & Enrollment
Phase 3
Dec 29, 2022
N/A
ICD-10 Classifications
Other chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, unspecified
Other specified chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
Chronic obstructive pulmonary disease with acute lower respiratory infection
Data Source
Philippine Health Research Registry
PHRR230822-006034
Non-Device Trial